Table 2 |
|||
|
Baseline patient characteristics compared between cases (n = 109) and controls (n = 218). |
|||
|
Demographics |
Cases (%) |
Controls (%) |
P-value |
|
|
|||
|
Age 75 or Older |
50 |
42 |
0.20* |
|
Female |
45 |
32 |
0.02* |
|
Nonwhite Race |
11 |
6 |
0.10* |
|
Hypertension |
48 |
47 |
0.99* |
|
Diabetes |
21 |
21 |
0.99* |
|
Coronary Artery Disease |
39 |
34 |
0.53* |
|
Follow up time |
10.9 months |
11.5 months |
< 0.001† |
|
# INR/month |
2.3 |
1.2 |
< 0.001† |
|
Indication: |
0.26* |
||
|
Atrial Fibrillation |
67 |
58 |
|
|
VTE |
11 |
13 |
|
|
Valvular Heart disease |
6 |
5 |
|
|
Other |
16 |
24 |
|
|
|
|||
|
*Comparison via Monte Carlo simulation †Comparison via Generalized Estimating Equations (GEE) |
|||
|
Marrast et al. Thrombosis Journal 2011 9:14 doi:10.1186/1477-9560-9-14 |
|||